Paris Hilton Buys A Bored Ape Yacht Club NFT, Chats About Tokens With Jimmy Fallon: Here’s Why It’s Important
During a television interview, Paris Hilton took time to highlight her involvement in the world of non-fungible tokens.
FDA Accepts Samsung Bioepis’ And Organon’s sBLA For Their Citrate-Free, High-Concentration HUMIRA Biosimilar Candidate
Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE:OGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for a
Organon Shares Volatile, Make Parabolic Move Higher Then Sell Off; FDA AccessData.gov Listing For Co.’s Mirtazapine Shows FDA Approved
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020415
Organon Q3 EPS $1.67 Beats $1.44 Estimate, Sales $1.60B Beat $1.58B Estimate
Organon (NYSE:OGN) reported quarterly earnings of $1.67 per share which beat the analyst consensus estimate of $1.44 by 15.97 percent. The company reported quarterly sales of $1.60 billion which beat the analyst
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell
• NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.
Piper Sandler Initiates Coverage On Organon with Neutral Rating, Announces Price Target of $35
Piper Sandler analyst David Amsellem initiates coverage on Organon (NYSE:OGN) with a Neutral rating and announces Price Target of $35.
Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling.
Morgan Stanley Maintains Equal-Weight on Organon, Raises Price Target to $35
Morgan Stanley analyst Matthew Harrison maintains Organon (NYSE:OGN) with a Equal-Weight and raises the price target from $33 to $35.